Correlation Between Opus Genetics, and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opus Genetics, and Vincerx Pharma, you can compare the effects of market volatilities on Opus Genetics, and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and Vincerx Pharma.
Diversification Opportunities for Opus Genetics, and Vincerx Pharma
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Opus and Vincerx is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Opus Genetics, and Vincerx Pharma
Considering the 90-day investment horizon Opus Genetics, is expected to generate 1.25 times more return on investment than Vincerx Pharma. However, Opus Genetics, is 1.25 times more volatile than Vincerx Pharma. It trades about 0.01 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.21 per unit of risk. If you would invest 117.00 in Opus Genetics, on September 4, 2024 and sell it today you would lose (2.00) from holding Opus Genetics, or give up 1.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Opus Genetics, vs. Vincerx Pharma
Performance |
| Timeline |
| Opus Genetics, |
| Vincerx Pharma |
Opus Genetics, and Vincerx Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opus Genetics, and Vincerx Pharma
The main advantage of trading using opposite Opus Genetics, and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.| Opus Genetics, vs. Hillman Solutions Corp | Opus Genetics, vs. Southwest Gas Holdings | Opus Genetics, vs. Kenon Holdings | Opus Genetics, vs. Transportadora de Gas |
| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |